Enovis buys eCential Robotics to expand surgical automation
Enovis has agreed to acquire eCential Robotics for about $180 million, adding a modular surgical robotics platform to its ASTRA ecosystem. The deal includes potential milestone payments and is expected to close by the end of 2026. eCential's technology has been used in spine and knee surgeries.
The binding offer includes an upfront payment of roughly $204 million at closing, with an additional $40.6 million possible if specific milestones are met. The transaction is slated to finalize by the end of 2026, bringing eCential's team of over 50 employees and its three previously launched robotic platforms into the Enovis fold.
The French firm's technology has already been deployed in clinical settings, including robotic spine procedures at an ambulatory surgery center in New Jersey. Enovis intends to leverage this validated technology to launch a next-generation knee robot within two years, followed by a shoulder system, a market where Enovis already holds a substantial global share.
This consolidation could accelerate the adoption of robotic assistance in orthopedic surgery, potentially improving precision and recovery times for patients undergoing knee and shoulder procedures. Surgeons may gain access to more adaptable, modular systems, while hospitals could face increased capital costs as automation becomes more standard. The move might also intensify competition among medical device makers, potentially driving innovation but also raising questions about the affordability and accessibility of advanced surgical care.